111, Inc.

    Jurisdiction
    China
    LEI
    549300IRZ6WV1NLO5Z75
    ISIN
    US68247Q2012 (YI)
    Sectors
    1. Healthcare
    2. Medical - Pharmaceuticals

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €1.71B
    Gross margin
    5.1%
    EBIT
    €251.53K
    EBIT margin
    0.0%
    Net income
    -€7.70M
    Net margin
    -0.4%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Product €14.29B 834.2%
    Drugs €13.40B 781.9%
    Nutritional Supplements €550.46M 32.1%
    Other Products €201.83M 11.8%
    Medical Supplies And Devices €144.28M 8.4%
    Service €106.51M 6.2%
    Mp Service €65.54M 3.8%
    Service, Other €40.97M 2.4%

    Earnings Calls

    Latest earnings call: May 23, 2024

    Add to watchlist

    Notifications